FOR IMMEDIATE RELEASE: Tampa, FL — October 18, 2024 — This Thanksgiving week, the Obesity Action Coalition (OAC) extends its gratitude to the Biden Administration for proposing a new rule significantly expanding access to obesity medications for Americans with Medicare and Medicaid coverage. “This is incredible. For more than a decade, the OAC, alongside partner
Read Article

The conversation around GLP-1 medications has grown louder in recent years, with these treatments showing great promise for managing obesity. However, challenges like supply shortages and affordability have created barriers for many individuals. In response, patients are turning to compounded GLP-1 medications as an alternative. Leading Conversations on GLP-1 Compounding At the Obesity Action Coalition
Read Article

ObesityWeek 2024 in San Antonio brought together more than 3,200 attendees to explore the latest science and policies around obesity. The OAC had the privilege of attending this esteemed conference once again, and we hosted a booth that engaged attendees with information about our mission, advocacy efforts and upcoming initiatives. Our new Stop Weight Bias
Read Article

The 2025 Open Enrollment period for many healthcare plans, including private insurance, Affordable Care Act (ACA) plans, Medicare and Medicaid, is now underway. Open Enrollment happens annually, giving you the chance to review your insurance coverage and make sure it meets your current healthcare needs. During this time, you can enroll in, re-enroll in, or
Read Article

The Obesity Action Coalition (OAC) believes in the importance of advocacy, especially sharing personal stories about living with obesity to change perceptions and eliminate stigma. Part of our work is also improving the way obesity is addressed in healthcare and educating health professionals. That’s why we were honored to team up with the Obesity Medicine
Read Article

Managing your weight and health is a journey, and we understand how frustrating it can be when promising treatments like Wegovy (semaglutide) or Zepbound (tirzepatide) are out of reach. With shortages and high costs, it’s tempting to consider other options, like compounded GLP-1 medications. But here’s why that’s a risky path you should avoid.  The
Read Article

seca, the premier company for medical body composition, has taken its role as a sponsor of the OAC from the Chairman’s Council to the next level with a commitment to donate 5% of all sales from the OMA, ASMBS and ObesityWeek conferences this year back to the OAC. seca is committed to supporting and empowering both
Read Article

Open enrollment for 2024 healthcare plans starts November 1, 2023, and ends January 15, 2024, in most states. Be sure to check your deadlines as some are shorter or longer. Open enrollment is a period that occurs annually and it’s the time to review your insurance coverage and assess whether it aligns with your current
Read Article

Obesity Action Coalition (OAC) calls on all Ohio residents to take action today to expand access to care. Join us in urging the Ohio Senate Finance Committee and Senate Leadership to support and pass House Bill 33, which includes language to expand coverage for comprehensive obesity treatments under Medicaid. OAC applauds the inclusion of comprehensive
Read Article

March 2nd – Obesity is a life-long disease needing comprehensive life-long healthcare. It’s important that everyone who is affected by obesity is given the option to receive fair and proper healthcare. There are healthcare providers who specialize in the treatment of obesity, obesity medicine specialists, that can provide patients with the tools and resources for long
Read Article